Paratek Pharmaceuticals

Paratek Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics. The company has created small molecules derived from the minocycline core structure. The company's NUZYRA? (omadacycline) is a once-daily oral and intravenous antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia, and acute skin and skin structure infections, caused by susceptible pathogens. In addition, SEYSARA? (sarecycline) is a once-daily oral therapy for the treatment of moderate to severe acne vulgaris, with respect to which the company has licensed in the United States certain rights to Almirall, LLC.
  • TickerPRTK
  • ISINUS6993743029
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

ValuEngine Rating and Forecast Report for PRTK

ValuEngine Rating and Forecast Report for PRTK

Wedbush Research

Wedbush Morning Call - May 26 2020 6:20AM

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Wedbush Research

Wedbush Morning Call - May 26 2020 6:20AM

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Wedbush Research

Wedbush Morning Call - May 18 2020 6:54AM

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for PRTK

ValuEngine Rating and Forecast Report for PRTK

ValuEngine Rating and Forecast Report for PRTK

ValuEngine Rating and Forecast Report for PRTK

ValuEngine Rating and Forecast Report for PRTK

ValuEngine Rating and Forecast Report for PRTK

ValuEngine Rating and Forecast Report for PRTK

ValuEngine Rating and Forecast Report for PRTK

ValuEngine Rating and Forecast Report for PRTK

ValuEngine Rating and Forecast Report for PRTK

ResearchPool Subscriptions

Get the most out of your insights

Get in touch